// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Do automatic CRT optimisation algorithms work? A comparison of techniques

NB Bloodworth - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

How is our local AF management? The management of atrial fibrillation (af) in coventry and rugby clinical commissioning group (ccg), england compared to national data and nice (national institute for clinical excellence) 2014

HR Eftekhari - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Prevalence and spectrum of genetic variants in a single-centre cohort of Brugada syndrome

L Wong - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Incidence of arrhythmias in Ebstein’s anomaly in a single centre

R Bond - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Heart rate variability evaluation in patients with long standing persistent atrial fibrillation treated with thoracoscopic surgical ablation with ganglionic plexi ablation or catheter ablation - recordings from implantable loop recorder

H Khan - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

USe of ultra-high density activation mapping to aid isthmus identification in atrial macro-reentrant tachycardias in complex congenital heart disease

CA Martin - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Relationship of conduction velocity and conduction velocity dynamics to bipolar voltage and drivers in atrial arrhythmia

S Honarbakhsh - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Post-mortem ICD interrogation in mode of death classification

T Nikolaidou - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Incorrect coding of atrial fibrillation leads to under-treatment with anticoagulation in pacing clinics

M Kahn - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Clinical evaluation of the ‘pulse smart rhythm analyst’: a novel software algorithm and pulse oximeter combination for mass screening of atrial fibrillation

MB Sayers - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

One-year outcomes of triple therapy and adherence with ESC guidelines in patients with AF undergoing PCI in a teaching hospital

A Saffy - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Warfarin

Differences in right and left atrial structure and electrophysiology in ARVD

R Martsinkevich - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Investigating the tissue response to radiofrequency ablation during left atrial posterior wall ablation: analysis of unipolar electrogram morphological changes following visitag-guided pulmonary vein isolation

D R Tomlinson - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Trans-coronary pacing to assess myocardial viability prior to percutaneous coronary intervention

J O'Neill - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Patient self-reported pain and contributing factors during the implant of cardiac implantable electronic devices

N Brewster - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

The role of permanent pacing following cardiac surgery. Appropriateness and timing of implants: a large tertiary single centre experience.

P H Waddingham - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Accuracy of test results for Direct Oral Anticoagulants (DOACs) and Warfarin- importance of External Quality Assessment (EQA)

DP Kitchen - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Warfarin

Working with community pharmacists to improve anticoagulation new medicine service discussions

Sharron Gordon - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Review of management of cardiac arrest and predictors of outcome in a large district general hospital “cardiac arrest centre”

M E Taylor - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Anticoagulation in atrial fibrillation – a single-centre audit on patient education, stroke and bleeding risk assessments and use of direct oral anticoagulants (DOACs)

SM Ng - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved